For: | Grabinska K, Pelak M, Wydmanski J, Tukiendorf A, d’Amico A. Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer. World J Gastroenterol 2015; 21(19): 5901-5909 [PMID: 26019454 DOI: 10.3748/wjg.v21.i19.5901] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i19/5901.htm |
Number | Citing Articles |
1 |
Minoru Tomizawa, Fuminobu Shinozaki, Yoshitaka Uchida, Katsuhiro Uchiyama, Kazunori Fugo, Takafumi Sunaoshi, Aika Ozaki, Eriko Sugiyama, Akira Baba, Yoshiya Fukamizu, Satoshi Kagayama, Rumiko Hasegawa, Yoshinori Shirai, Yuji Oshima, Naoto Koike, Yasuko Toshimitsu, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Takashi Kishimoto, Naoki Ishige. Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion and positron emission tomography/computed tomography of upper gastrointestinal cancers. Abdominal Imaging 2015; 40(8): 3012 doi: 10.1007/s00261-015-0545-2
|
2 |
Lei Tang, Xue-Juan Wang, Hideo Baba, Francesco Giganti. Gastric cancer and image-derived quantitative parameters: Part 2—a critical review of DCE-MRI and 18F-FDG PET/CT findings. European Radiology 2020; 30(1): 247 doi: 10.1007/s00330-019-06370-x
|
3 |
Suk‐young Lee, Hyo Jung Seo, Sungeun Kim, Jae Seon Eo, Sang Cheul Oh. Prognostic significance of interim 18F‐fluorodeoxyglucose positron emission tomography–computed tomography volumetric parameters in metastatic or recurrent gastric cancer. Asia-Pacific Journal of Clinical Oncology 2018; 14(5) doi: 10.1111/ajco.12833
|
4 |
Michihiro Kudou, Toshiyuki Kosuga, Takeshi Kubota, Kazuma Okamoto, Shuhei Komatsu, Katsutoshi Shoda, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Tomohiro Arita, Ryo Morimura, Yasutoshi Murayama, Yoshiaki Kuriu, Hisashi Ikoma, Masayoshi Nakanishi, Eigo Otsuji. Value of Preoperative PET-CT in the Prediction of Pathological Stage of Gastric Cancer. Annals of Surgical Oncology 2018; 25(6): 1633 doi: 10.1245/s10434-018-6455-0
|
5 |
FENG LAN, MING ZHU, QIUFENG QI, YAPING ZHANG, YONGPING LIU. Prognostic value of serum tumor abnormal protein in gastric cancer patients. Molecular and Clinical Oncology 2016; 5(1): 216 doi: 10.3892/mco.2016.877
|
6 |
Ji Soo Park, Nare Lee, Seung Hoon Beom, Hyo Song Kim, Choong-kun Lee, Sun Young Rha, Hyun Cheol Chung, Mijin Yun, Arthur Cho, Minkyu Jung. The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status. Gastric Cancer 2018; 21(2): 213 doi: 10.1007/s10120-017-0739-0
|
7 |
Alejandro Cepero, Yidong Yang, Lori Young, Jianfeng Huang, Xuemei Ji, Fei Yang. Longitudinal FDG-PET Radiomics for Early Prediction of Treatment Response to Chemoradiation in Locally Advanced Cervical Cancer: A Pilot Study. Cancers 2024; 16(22): 3813 doi: 10.3390/cancers16223813
|
8 |
Paolo Aurello, Niccolò Petrucciani, Laura Antolino, Diego Giulitti, Francesco D'Angelo, Giovanni Ramacciato. Follow-up after curative resection for gastric cancer: Is it time to tailor it?. World Journal of Gastroenterology 2017; 23(19): 3379-3387 doi: 10.3748/wjg.v23.i19.3379
|
9 |
Germán Andrés Jiménez Londoño, Ana Maria García Vicente, Jesús J. Bosque, Mariano Amo-Salas, Julián Pérez-Beteta, Antonio Francisco Honguero-Martinez, Víctor M. Pérez-García, Ángel María Soriano Castrejón. SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients. European Radiology 2022; 32(6): 3889 doi: 10.1007/s00330-021-08523-3
|
10 |
M.J. Tello Galán, A.M. García Vicente, J. Pérez Beteta, M. Amo Salas, G.A. Jiménez Londoño, F.J. Pena Pardo, Á.M. Soriano Castrejón, V.M. Pérez García. Medidas de heterogeneidad global y esfericidad con 18F-FDG PET/TC en el cáncer de mama: relación con la biología tumoral, valor predictivo y pronóstico. Revista Española de Medicina Nuclear e Imagen Molecular 2019; 38(5): 290 doi: 10.1016/j.remn.2019.02.004
|
11 |
Varun Manoharan, Soon Lee, Shanley Chong, June Yap, Nick Coupe, Robert Wilson, Neil Merrett, Weng Ng, Michael Lin. Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy. Annals of Nuclear Medicine 2017; 31(4): 315 doi: 10.1007/s12149-017-1159-2
|
12 |
Minoru Tomizawa, Fuminobu Shinozaki, Yoshitaka Uchida, Katsuhiro Uchiyama, Kazunori Fugo, Takafumi Sunaoshi, Aika Ozaki, Eriko Sugiyama, Akira Baba, Daisuke Kano, Misaki Shite, Ryota Haga, Yoshiya Fukamizu, Satoshi Kagayama, Rumiko Hasegawa, Yoshinori Shirai, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Takashi Kishimoto, Naoki Ishige. Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion for the diagnosis of colorectal polyp and cancer. Experimental and Therapeutic Medicine 2017; 13(2): 639 doi: 10.3892/etm.2016.3981
|
13 |
Minoru Tomizawa, Fuminobu Shinozaki, Yoshitaka Uchida, Katsuhiro Uchiyama, Satomi Tanaka, Takafumi Sunaoshi, Daisuke Kano, Eriko Sugiyama, Misaki Shite, Ryouta Haga, Yoshiya Fukamizu, Toshiyuki Fujita, Satoshi Kagayama, Rumiko Hasegawa, Yoshinori Shirai, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige. Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity. Experimental and Therapeutic Medicine 2017; 14(4): 3754 doi: 10.3892/etm.2017.4987
|
14 |
María Jesús Tello Galán, Ana María García Vicente, Julián Pérez Beteta, Mariano Amo Salas, Germán Andrés Jiménez Londoño, Francisco José Pena Pardo, Ángel María Soriano Castrejón, Víctor Manuel Pérez García. Global heterogeneity assessed with 18F-FDG PET/CT. Relation with biological variables and prognosis in locally advanced breast cancer. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2019; 38(5): 290 doi: 10.1016/j.remnie.2019.03.002
|
15 |
Pilar Perlaza, Jaime Ortín, Mario Pagès, Elvira Buxó, Gloria Fernández-Esparrach, Patrick M. Colletti, Domenico Rubello, Maria Mayoral, Nuria Sánchez, Cristina Ruiz, Angels Ginés, David Fuster. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?. Clinical Nuclear Medicine 2018; 43(6): 402 doi: 10.1097/RLU.0000000000002028
|
16 |
Ana María García Vicente, Julian Pérez-Beteta, Mariano Amo-Salas, Francisco José Pena Pardo, Maikal Villena Martín, Hernán Sandoval Valencia, Manuela Mollejo Villanueva, Rosa Barbella, Christoph José Klein Zampaña, José María Borrás Moreno, Ángel María Soriano Castrejón, Víctor Manuel Pérez-García. 18F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for Gliomas. Clinical Nuclear Medicine 2019; 44(10): e548 doi: 10.1097/RLU.0000000000002715
|
17 |
Jessie Han, Luke Harrison, Lisa Patzelt, Mingming Wu, Daniela Junker, Stephan Herzig, Mauricio Berriel Diaz, Dimitrios C. Karampinos. Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00834-2
|
18 |
Iman Sherif Ahmed, Saher Mohamed El Gaafary, Remon Zaher Elia, Rasha S. Hussein. FDG-PET/CT in predicting aggressiveness of rectal cancer. Egyptian Journal of Radiology and Nuclear Medicine 2021; 52(1) doi: 10.1186/s43055-021-00656-1
|
19 |
Sara Pellegrino, Davide Origlia, Erica Di Donna, Martina Lamagna, Roberta Della Pepa, Fabrizio Pane, Silvana Del Vecchio, Rosa Fonti. Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma. Annals of Hematology 2024; 103(9): 3713 doi: 10.1007/s00277-024-05905-7
|
20 |
Kieran G Foley, Will Coomer, Bernadette Coles, Kevin M Bradley. The impact of baseline 18F-FDG PET-CT on the management and outcome of patients with gastric cancer: a systematic review. The British Journal of Radiology 2022; 95(1139) doi: 10.1259/bjr.20220437
|
21 |
Jerzy Kawiak, Grazyna Hoser, Joanna Domagała-Kulawik. Problems of Cancer Treatment. Part I. Theory of Treatment Based on Known Mechanisms of Anticancer Immunological Responses. Advances in Cell Biology 2017; 5(1): 72 doi: 10.1515/acb-2017-0006
|
22 |
Charles Marcus, Rathan M. Subramaniam. PET/Computed Tomography and Precision Medicine. PET Clinics 2017; 12(4): 437 doi: 10.1016/j.cpet.2017.05.004
|
23 |
Ewa Burchardt, Agnieszka Bos-Liedke, Kamila Serkowska, Paulina Cegla, Adam Piotrowski, Julian Malicki. Value of [18F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-35843-9
|
24 |
Danyu Ma, Ying Zhang, Xiaoliang Shao, Chen Wu, Jun Wu. PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer. Current Oncology 2022; 29(9): 6523 doi: 10.3390/curroncol29090513
|
25 |
Gaofeng Sun, Chao Cheng, Xiao Li, Tao Wang, Jian Yang, Danni Li. Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer. Cancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0205-9
|
26 |
Jun Hua, Lan Li, Lisheng Liu, Qi Liu, Ying Liu, Xiaoliang Chen. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non–small cell lung cancer. Nuclear Medicine Communications 2021; 42(11): 1247 doi: 10.1097/MNM.0000000000001456
|
27 |
A. Schernberg, E. Rivin del Campo, B. Rousseau, O. Matzinger, M. Loi, P. Maingon, F. Huguet. Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives. Clinical and Translational Radiation Oncology 2018; 10: 13 doi: 10.1016/j.ctro.2018.02.005
|
28 |
Shigeki Kobayashi, Mayumi Ogura, Naohisa Suzawa, Noriyuki Horiki, Masaki Katsurahara, Toru Ogura, Hajime Sakuma. 18F-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis. BMC Medical Imaging 2016; 16(1) doi: 10.1186/s12880-016-0161-9
|